Hunan Fangsheng Pharmaceutical Co (SHSE:603998) EPS (Basic) : ¥0.63 (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co EPS (Basic)?

Hunan Fangsheng Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was ¥0.20. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.63.

Hunan Fangsheng Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2025 was ¥0.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.62.

Hunan Fangsheng Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2025 was ¥0.16. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was 0.62.

During the past 12 months, Hunan Fangsheng Pharmaceutical Co's average EPS without NRIGrowth Rate was 43.40% per year. During the past 3 years, the average EPS without NRI Growth Rate was 61.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 40.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hunan Fangsheng Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 61.30% per year. The lowest was -28.30% per year. And the median was -2.90% per year.

Hunan Fangsheng Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co EPS (Basic) Chart

Hunan Fangsheng Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

Get a 7-Day Free Trial

0.15

0.16

0.66

0.43

0.59

Hunan Fangsheng Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial															0.16	0.16	0.21	0.06	0.20

Hunan Fangsheng Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Hunan Fangsheng Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(255.216	-	0)	/	432.570
	=	0.59

Hunan Fangsheng Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(88.258	-	0)	/	441.290
	=	0.20

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.63

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Hunan Fangsheng Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Fangsheng Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » EPS (Basic)

Traded in Other Exchanges

N/A

Address

No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN

Website

http://www.fangsheng.com.cn

Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.

Executives

He Shi	senior management
Xiao Han Qing	senior management
Liu Xin He	senior management
Chen Bo	Director
Chen Ai Chun	Director
Li Zhi Heng	senior management
Zhou Wei En	senior management
Zhang Qing Hua	Director
Huang Min	Director
Zhou Xiao Li	senior management
Fang Jin Cheng	Director
Fang Chuan Long	Supervisors
Tan Yuan Ming	Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines